KAPAInvestor•businesswire•
Kairos Pharma to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Sentiment:Negative (30)
Summary
(KAPA) LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces that John Yu, MD, CEO and Chairman, will present a corporate overview at the H.C. Wainwright 27th Annual Global Investment Conference. The conference is being held on September 8 – 10, 2025 at the Lotte New York Palace Hotel. Presentation Date: September 5, 2025 Time: Available on-demand starting at 7:00 AM Eastern Time
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 2, 2025 by businesswire